MODERN DIAGNOSTIC METHODS OF MYOCARDIAL INFARCTION
Keywords:
Myocardial infarction, cardiac biomarkers, troponin, cardiac MRI, MSCT angiography, diagnostic algorithmsAbstract
This article analyzes modern methods for diagnosing acute myocardial infarction, including the role of highly sensitive cardiac biomarkers, electrocardiographic changes, and visualization technologies such as MRI and CT. The study highlights the importance of 0/1-hour algorithms for cardiac biomarkers and the significance of cardiac MRI in determining myocardial viability. The obtained results confirm the effectiveness of modern multislice computed tomography as a non-invasive method of coronary angiography. In conclusion, the use of complex diagnostic methods plays a crucial role in the early detection of myocardial infarction and in the prevention of complications.
References
1.Collet, J. P., et al. (2021). 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367.
2.GBD 2019 Risk Factors Collaborators. (2020). Global burden of hypertension and risk factors. The Lancet, 396(10258), 1223–1249.
3.Oparil, S., et al. (2018). Hypertension and cardiovascular complications. Nature Reviews Disease Primers, 4(1), 1–22.
4.O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi (O‘zR SSV). (2024). “O‘tkir miokard infarkti” bo‘yicha milliy klinik protokoli. Respublika ixtisoslashtirilgan kardiologiya ilmiy-amaliy tibbiyot markazi.
5.Thygesen, K., et al. (2018). Fourth Universal Definition of Myocardial Infarction. Journal of the American College of Cardiology, 72(18), 2231–2264.
6.Valenzuela, P. L., et al. (2021). Lifestyle and cardiovascular risk management. Nature Reviews Cardiology, 18(5), 313–335.
7. World Health Organization (WHO). (2025). Cardiovascular diseases fact sheet.
8.World Health Organization (WHO). (2023). Global report on cardiovascular health and hypertension.
9.Ezzati, M., & Riboli, E. (2013). Behavioral and dietary risk factors for noncommunicable diseases. New England Journal of Medicine, 369(10), 954–964.
10.GBD 2019 Risk Factors Collaborators. (2020). Global burden of hypertension and risk factors. The Lancet, 396(10258), 1223–1249.
11.Hall, J. E., et al. (2015). Obesity-induced hypertension. Circulation Research, 116(6), 991–1006.